The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A response to the cochrane collaboration review of 2011

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 12, 2011, Pages 1693-1696

  Ray Jr , Charles E R ^a   Haskal, Ziv J ^b   Geschwind, Jean Francois H ^c   Funaki, Brian S ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

HCC; hepatocellular carcinoma

Indexed keywords

INSULIN; PLACEBO; TAMOXIFEN;

ABLATION THERAPY; ALCOHOL ABLATION; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL PRACTICE; COCHRANE LIBRARY; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; HUMAN; INSULIN TREATMENT; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MEDICAL PRACTICE; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOFREQUENCY IDENTIFICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STUDY DESIGN; SYSTEMATIC ERROR; TREATMENT OUTCOME;

EID: 81855221737     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.09.014     Document Type: Note

References (41)

1. R.A. Oliveri, J. Wetterslev, and C. Gluud Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma Cochrane Database Syst Rev 16 2011 CD004787
2. G. Pelletier, A. Roche, and O. Ink A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma J Hepatol 11 1990 181 184
3. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma N Engl J Med 332 1995 1256 1261
4. J. Bruix, J.M. Llovet, and A. Castells Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution Hepatology 27 1998 1578 1583 (Pubitemid 28264682)
5. G. Pelletier, M. Ducreux, and F. Gay Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial Groupe CHC J Hepatol 29 1998 129 134 (Pubitemid 28307992)
6. J.M. Llovet, M.I. Real, and X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trail Lancet 359 2002 1734 1739 (Pubitemid 34607087)
7. C.M. Lo, H. Ngan, and W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171 (Pubitemid 34454013)
8. M. Akamatsu, H. Yoshida, and S. Obi Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellullar carcinoma: a randomized controlled trial Liver Int 24 2004 625 629
9. M. Doffoel, F. Bonnetain, and O. Bouche Multicentre randomised phase III trial comparing tamoxifen alone or with transarterial lipiodol chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients Eur J Cancer 44 2008 528 538
10. C. Camma, F. Shepis, and A. Orlando Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 2002 47 54 (Pubitemid 34680374)
11. J.M. Llovet, J. Bruix Barcelona-Clinic Cancer Group Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442 (Pubitemid 36152543)
12. J.F. Geschwind, D.E. Ramsey, M.A. Choti, P.J. Thuluvath, and M.S. Huncharek Chemoembolization of hepatocellular carcinoma: results of a metaanalysis Am J Clin Oncol 26 2003 344 349 (Pubitemid 36962074)
13. J.L. Raoul, B. Sangro, and A. Forner Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization Cancer Treat Rev 37 2011 212 220
14. V. Clifford The placebo mystique: implications for clinical trial methodology J Paediatr Child Health 47 2011 361 366
15. D.Y. Lin, Y.F. Liaw, T.Y. Lee, and C.M. Lai Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma Gastroenterology 94 1988 453 456
16. S. Kawai, J. Okamura, and M. Ogawa Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma: a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study) Cancer Chemother Pharmacol 31 Suppl 1 1992 S1 S6
17. J.M. Chang, W.S. Tzeng, H.B. Pan, F.C. Yang, and K.H. Lai Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma Cancer 74 1994 2449 2453
18. S. Kawai, M. Tani, and J. Okamura Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma: a comparison between L-TAE with farmorubicin and L-TAE with adriamycinpreliminary results (second cooperative study) Cancer Chemother Pharmacol 33 Suppl 1994 S97 S102
19. C. Lu, Y. Qi, and S. Peng Lipiodolization with or without gelatin sponge in hepatic chemoembolization for hepatocellular carcinoma Chin Med J (Engl) 107 1994 209 215
20. S. Watanabe, M. Nishioka, Y. Ohta, N. Ogawa, S. Ito, and Y. Yamamoto Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma Cooperative Study Group for Liver Cancer Treatment in Shikoku area Cancer Chemother Pharmacol 33 Suppl 1994 S93 S96
21. M. Yoshikowa, H. Saisho, and M. Ebara A randomized trial of intrahepatic arterial infusion of 4'-epidoxorubicin with lipiodol versus 4'-epidoxorubicin alone in the treatment of hepatocellular carcinoma Cancer Chemother Pharmacol 33 Suppl 1994 S149 S152
22. K. Ikeda, S. Saitoh, and I. Koida A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization Am J Clin Oncol 18 1995 204 210
23. K. Ikeda, S. Saitoh, and Y. Suzuki A prospective randomized administration of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization Am J Clin Oncol 20 1997 202 208 (Pubitemid 27152779)
24. S. Kawai, M. Tani, and J. Okamur Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study) The Cooperative Study Group for Liver Cancer Treatment of Japan Semin Oncol 24 Suppl 6 1997 38 45
25. P.C. Kwok, T.W. Lam, and S.C. Chan A randomized clinical trial comparing autologous blood clot and Gelfoam in transarterial chemoembolization for inoperable hepatocellular carcinoma J Hepatol 32 2000 955 964 (Pubitemid 30368089)
26. C. Camma, F. Schepis, and A. Orlando Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 2002 47 54 (Pubitemid 34680374)
27. D.E. Ramsey, and J.F. Geschwind Chemoembolization of hepatocellular carcinomawhat to tell the skeptics: review and meta-analysis Tech Vasc Interv Radiol 5 2002 122 126 (Pubitemid 36078167)
28. K.S. Chok, K.K. Ng, and R.T. Poon Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization Arch Surg 141 2006 1231 1236 (Pubitemid 44956641)
29. S. Dharancy, J. Boitard, and T. Decaens Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study Liver Transpl 13 2007 665 671 (Pubitemid 46796537)
30. L. Marelli, R. Stigliano, and C. Triantos Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25 (Pubitemid 44900485)
31. A.S. Gomes, M.H. Rosove, and P.J. Rosen Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients AJR Am J Roentgenol 193 2009 1665 1671
32. M. Mabed, M. Esmaeel, T. El-Khodary, M. Awad, and T. Amer A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma Eur J Cancer Care (Engl) 18 2009 492 499
33. G. Cabibbo, M. Enea, M. Attanasio, J. Bruix, A. Craxi, and C. Camma A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma Hepatology 51 2010 1274 1283
34. D.V. Kooby, V. Egnatashvili, and S. Srinivasan Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma J Vasc Interv Radiol 21 2010 224 230
35. J. Lammer, K. Malagari, T. Volgl PRECISION V Investigators Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol 33 2010 41 52
36. K.S. Puri, K.R. Suresh, N.J. Gogtay, and U.M. Thatte Declaration of Helsinki, 2008: implications for stakeholders in research J Postgrad Med 55 2009 131 134
37. World Medical Association Declaration of HelsinkiEthical principles for medical research involving human subjects http://www.wma.net/en/30publications/ 10policies/b3/index.html Accessed July 11, 2011
38. D. Galandi, and G. Antes Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma Cochrane Database Syst Rev 2009 CD003046
39. D.L. Sackett, S.E. Straus, W.S. Richardson, W. Rosenberg, and R.B. Haynes Therapy Evidence-Based Medicine How to Practice and Teach EBM 2nd ed. 2000 Churchill Livingstone Edinburgh 105 154
40. P. Glasziou, I. Chalmers, M. Rawlins, and P. McCulloch When are randomised trials unnecessary? Picking signal from noise BMJ 334 2007 349 351 (Pubitemid 46328045)
41. C. Gordon, and S. Smith Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomize controlled trials BMJ 327 2003 1459 1461